Viatris Aktie

Viatris für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2QAME / ISIN: US92556V1061

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
27.02.2025 13:14:50

Viatris Guides FY25 Well Below Estimates - Update

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, healthcare company Viatris Inc. (VTRS) initiated its adjusted earnings and revenue guidance for the full-year 2025.

For fiscal 2025, the company now projects adjusted earnings in a range of $2.12 to $2.26 per share on total revenues between $13.50 billion and $14.00 billion.

On average, analysts polled expect the company to report earnings of $2.59 per share on net sales of $14.22 billion for the year. Analysts' estimates typically exclude special items.

The company also announced that its Board of Directors approved a 2025 dividend policy of $0.48 per share and declared a quarterly dividend of $0.12 for each issued and outstanding share of the Company's common stock, payable on March 18, 2025, to shareholders of record at the close of business on March 10, 2025.

The company said it plans to prioritize capital return in 2025, including $500 million to $650 million in share repurchases.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Analysen zu Viatris Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Viatris Inc Registered Shs 8,38 -1,64% Viatris Inc Registered Shs